A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats

F. Lugarini, B. J. Hrupka, Gary J. Schwartz, C. R. Plata-Salaman, W. Langhans

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Because nonselective cycloooxygenase (COX) inhibition attenuated anorexia after lipopolysaccharide (LPS) administration, we tested the ability of resveratrol (2.5, 10, and 40 mg/kg) and NS-398 (2.5, 10, and 40 mg/kg), selective inhibitors of the two COX isoforms COX-1 and -2, respectively, to attenuate LPS (100 μg/kg ip)-induced anorexia. NS-398 (10 and 40 mg/kg) administered with LPS at lights out attenuated LPS-induced anorexia, whereas resveratrol at all doses tested did not. Because prostaglandin (PG) E2 is considered the major metabolite synthesized by COX, we measured plasma and cerebrospinal fluid (CSF) PGE2 levels after LPS administration. LPS induced a time-dependent increase of PGE2 in CSF but not in plasma. NS-398 (5, 10, and 40 mg/kg) blocked the LPS-induced increase in CSF PGE2, whereas resveratrol (10 mg/kg) did not. These results support a role of COX-2 in mediating the anorectic response to peripheral LPS and point at PGE2 as a potential neuro-modulator involved in this response.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume283
Issue number4 52-4
StatePublished - Oct 2002
Externally publishedYes

Fingerprint

Anorexia
Cyclooxygenase 2
Lipopolysaccharides
Dinoprostone
Cerebrospinal Fluid
Appetite Depressants
Protein Isoforms
Light
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
resveratrol

Keywords

  • Fever
  • Food intake
  • NS-398
  • Prostaglandin E
  • Resveratrol

ASJC Scopus subject areas

  • Physiology

Cite this

A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. / Lugarini, F.; Hrupka, B. J.; Schwartz, Gary J.; Plata-Salaman, C. R.; Langhans, W.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 283, No. 4 52-4, 10.2002.

Research output: Contribution to journalArticle

@article{b11b8217f1a54589b2c8e3b020bb76b7,
title = "A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats",
abstract = "Because nonselective cycloooxygenase (COX) inhibition attenuated anorexia after lipopolysaccharide (LPS) administration, we tested the ability of resveratrol (2.5, 10, and 40 mg/kg) and NS-398 (2.5, 10, and 40 mg/kg), selective inhibitors of the two COX isoforms COX-1 and -2, respectively, to attenuate LPS (100 μg/kg ip)-induced anorexia. NS-398 (10 and 40 mg/kg) administered with LPS at lights out attenuated LPS-induced anorexia, whereas resveratrol at all doses tested did not. Because prostaglandin (PG) E2 is considered the major metabolite synthesized by COX, we measured plasma and cerebrospinal fluid (CSF) PGE2 levels after LPS administration. LPS induced a time-dependent increase of PGE2 in CSF but not in plasma. NS-398 (5, 10, and 40 mg/kg) blocked the LPS-induced increase in CSF PGE2, whereas resveratrol (10 mg/kg) did not. These results support a role of COX-2 in mediating the anorectic response to peripheral LPS and point at PGE2 as a potential neuro-modulator involved in this response.",
keywords = "Fever, Food intake, NS-398, Prostaglandin E, Resveratrol",
author = "F. Lugarini and Hrupka, {B. J.} and Schwartz, {Gary J.} and Plata-Salaman, {C. R.} and W. Langhans",
year = "2002",
month = "10",
language = "English (US)",
volume = "283",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4 52-4",

}

TY - JOUR

T1 - A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats

AU - Lugarini, F.

AU - Hrupka, B. J.

AU - Schwartz, Gary J.

AU - Plata-Salaman, C. R.

AU - Langhans, W.

PY - 2002/10

Y1 - 2002/10

N2 - Because nonselective cycloooxygenase (COX) inhibition attenuated anorexia after lipopolysaccharide (LPS) administration, we tested the ability of resveratrol (2.5, 10, and 40 mg/kg) and NS-398 (2.5, 10, and 40 mg/kg), selective inhibitors of the two COX isoforms COX-1 and -2, respectively, to attenuate LPS (100 μg/kg ip)-induced anorexia. NS-398 (10 and 40 mg/kg) administered with LPS at lights out attenuated LPS-induced anorexia, whereas resveratrol at all doses tested did not. Because prostaglandin (PG) E2 is considered the major metabolite synthesized by COX, we measured plasma and cerebrospinal fluid (CSF) PGE2 levels after LPS administration. LPS induced a time-dependent increase of PGE2 in CSF but not in plasma. NS-398 (5, 10, and 40 mg/kg) blocked the LPS-induced increase in CSF PGE2, whereas resveratrol (10 mg/kg) did not. These results support a role of COX-2 in mediating the anorectic response to peripheral LPS and point at PGE2 as a potential neuro-modulator involved in this response.

AB - Because nonselective cycloooxygenase (COX) inhibition attenuated anorexia after lipopolysaccharide (LPS) administration, we tested the ability of resveratrol (2.5, 10, and 40 mg/kg) and NS-398 (2.5, 10, and 40 mg/kg), selective inhibitors of the two COX isoforms COX-1 and -2, respectively, to attenuate LPS (100 μg/kg ip)-induced anorexia. NS-398 (10 and 40 mg/kg) administered with LPS at lights out attenuated LPS-induced anorexia, whereas resveratrol at all doses tested did not. Because prostaglandin (PG) E2 is considered the major metabolite synthesized by COX, we measured plasma and cerebrospinal fluid (CSF) PGE2 levels after LPS administration. LPS induced a time-dependent increase of PGE2 in CSF but not in plasma. NS-398 (5, 10, and 40 mg/kg) blocked the LPS-induced increase in CSF PGE2, whereas resveratrol (10 mg/kg) did not. These results support a role of COX-2 in mediating the anorectic response to peripheral LPS and point at PGE2 as a potential neuro-modulator involved in this response.

KW - Fever

KW - Food intake

KW - NS-398

KW - Prostaglandin E

KW - Resveratrol

UR - http://www.scopus.com/inward/record.url?scp=0036784568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036784568&partnerID=8YFLogxK

M3 - Article

VL - 283

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 4 52-4

ER -